Conference Day 1

Day One

Tuesday December 6, 2022

7:20 am Conference Registration & Networking

8:20 am Welcome From the ESG: Life Sciences Team

8:25 am Chair’s Welcome, Opening Remarks & Connection Before Content

  • Victoria Emerick Global Head of Corporate Sustainability Strategy & Operations, Bristol Myers Squibb

Defining, Implementing & Aligning Your ESG Strategy

8:30 am Keynote Panel: What Does ESG Really Mean for the Life Science Industry?

  • Victoria Emerick Global Head of Corporate Sustainability Strategy & Operations, Bristol Myers Squibb
  • Daniella Foster Executive Board Member & Senior Vice President, Public Affairs, Science & Sustainability, Consumer Health, Bayer
  • Chris Gray Head of ESG, Pfizer
  • Johanna Jobin Global Head, Corporate Reputation & Responsibility, Biogen

Synopsis

  • To what extent are the current ESG protocols in life sciences organizations fit for purpose?
  • How do we define and report what good looks like?
  • What can leading ESG change-makers do to transform existing protocols to ensure life science organizations are doing the most to be ESG conscious in 2023 and beyond?

9:10 am Discover: Enhancing Brand Authenticity & Health in an Era of Mandatory ESG Reporting

  • Brian Henry Managing Director, ESG Transformation Practice, PwC
  • Rich Goode Partner, ESG Trust Practice, PwC

Synopsis

  • Are current product safety, environmental stewardship, and health equity programs maximizing brand health? Are actions taken across the enterprise consistent with the stated corporate purpose, values, and ambitions?
  • Can a tightening ESG regulatory environment be a catalyst for enterprise creativity, innovation, and transformation? Does the corporate IT infrastructure provide timely ESG data, analytics, and context-specific insight?
  • Are my company’s corporate and ESG strategies aligned? If so, does the current operating model allow for seamless delivery of priority KPI’s?

9:40 am Discover: Broadening the Definition of Corporate Responsibility to Feed Into A Holistic View of ESG

  • Byron Austin Head, Corporate Responsibility & ESG Management, Organon Pharmaceuticals

Synopsis

  • Building infrastructure to support ESG initiatives, determine ESG owners and integrate stakeholder focused teams
  • Efficiently identifying and selecting sustainable vendors to ensure maximal ESG ratings across the ESG value chain
  • How Organon are challenging the reliance of ESG profile measurements to give value to intangible assets in corporate responsibility & ESG settings

10:00 am Develop: What Else Can We Learn From ESG Executors on How To Define What ESG Means For the Life Sciences Industry?

  • Byron Austin Head, Corporate Responsibility & ESG Management, Organon Pharmaceuticals
  • Victoria Emerick Global Head of Corporate Sustainability Strategy & Operations, Bristol Myers Squibb

Synopsis

Question & Answer Session Facilitated by the Chair

10:20 am Action: How Will You Define & Settle On Your Organization’s Own ESG Strategy With Your Unique Governance Structure & Product Profile?

Synopsis

Output Focused Action Session Facilitated by the Chair

10:40 am Speed Networking Break

Optimizing ESG Standards Assessment & Reporting to Communicate Impactful ESG Agendas

11:30 am Panel Discussion: Navigating the shifting ESG landscape & reporting standards to develop an inaugural ESG report

Synopsis

  • Monitoring challenges and understanding expectations to engage a wide variety of stakeholders
  • Engaging reporting agencies to understand ESG ratings and prioritize reporting and focus working
    groups
  • Optimizing resources and obtaining internal support to progress ESG efforts

11:50 am Discover: Leveraging ESG Rating Agencies to Launch an ESG Structure & Program To Reflect Your Organization’s Mission While Illuminating Stakeholder Voices

Synopsis

  • Assessing your starting position to effectively build out an ESG framework from scratch to ensure correct funnelling of resources
  • Engaging correctly with rating agencies to dissect the right information and understand the return of investment of different practices
  • How Twist Bioscience settled with their own ESG strategy based on their unique product profile to keep stakeholders happy while staying true to organizational principals

12:10 pm Develop: What Else Can We Learn From Corporate Communications Leaders in How to Assess & Report Your ESG Standards to Stakeholders?

Synopsis

Question & Answer Session Facilitated by the Chair

12:30 pm Action: What Will You Revaluate to Effectively Assess Your Organizations ESG Standards & Frameworks?

Synopsis

Output Focused Action Session Facilitated by the Chair

12:50 pm Lunch & Networking

Improving Health Access To The Communities You Serve

2:10 pm Discover: Pivoting the Definition of Sustainability to Encompass Environmental Initiatives AND Human Health to Spark Long-Term Global Impacts

  • Victoria Emerick Global Head of Corporate Sustainability Strategy & Operations, Bristol Myers Squibb

Synopsis

  • Building a patient-centred approach to define what social and environmental sustainability mean to patients to serve organization-specific communities
  • Learning about the intersectionality between the environment and human health to develop sustainable solutions to promote global health
  • How BMS’ environmental initiatives are contributing to long-term economic viability and human health

2:30 pm Discover: Grasping the Role of Human Resources in Enabling ESG

Synopsis

  • Identifying key impact clusters with internal and external stakeholders to shape and drive ESG strategy
  • Setting a culture of diversity and inclusion
  • Partnering with healthcare systems to innovate access models

2:50 pm Develop: How Can We Effectively Create Access Frameworks to Make Health More Accessible For All?

  • Victoria Emerick Global Head of Corporate Sustainability Strategy & Operations, Bristol Myers Squibb
  • Christopher Howarth Head People & Organization, Innovative Medicines International, Novartis

Synopsis

Question & Answer Session Facilitated by the Chair

3:10 pm Action: What Will You Do Differently In Your Organization to Improve Health Access to the Communities You Serve?

Synopsis

Output Focused Action Session Facilitated by the Chair

3:30 pm End of Day One